The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Jun 2017 12:11

RNS Number : 0848I
Electrocomponents PLC
14 June 2017
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Electrocomponents plc

LEI: 549300KVXDURRKVW7R37

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Silchester International Investors LLP

4. Full name of shareholder(s) (if different from 3.):iv

Silchester International Investors International Value Equity Taxable Trust

 

Silchester International Investors International Value Equity Trust

 

Silchester International Investors International Value Equity Group Trust

 

Silchester International Investors Tobacco Free International Value Equity Trust

 

The Calleva Trust

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

13th June 2017

6. Date on which issuer notified:

14th June 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 12%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003096442

57,367,320

57,367,320

 

 

52,850,989

 

11.97%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

 

Nominal

Delta

N/A

N/A

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,850,989

11.97%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

 

Proxy Voting:

10. Name of the proxy holder:

Silchester International Investors LLP

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

Silchester International Investors LLP ("Silchester") acts as investment manager for the clients detailed in Question 4 above (our "Clients"). In acting for our Clients, Silchester are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Clients' custodian and therefore shares are not held in our name but in the name of each Client's custodian bank.

 

The change in Silchester's holdings was due to a series of transactions over a series of different trading days. Details of the number of shares held before the change (shown in Section A) represent the shares held by Silchester's clients as of the date of our last Notice of Substantial Shareholder's Interest (a notification of crossing below 14% of Electrocomponent's voting rights) and not as of the last trading day before which this disclosure was triggered.

 

Notification is provided based on a total voting rights figure of 441,551,793.

14. Contact name:

Timothy J. Linehan, Senior Partner

15. Contact telephone number:

0207 518 7125

   
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUQUQUPMGGC
Date   Source Headline
28th Jun 202110:00 amRNSNotice of Trading Update
25th Jun 20212:30 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
15th Jun 202112:00 pmRNSAnnual Financial Report
10th Jun 202111:00 amRNSDirector/PDMR Shareholding
1st Jun 20219:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results
24th May 20213:00 pmRNSHolding(s) in Company
4th May 20213:00 pmRNSDirector Declaration
4th May 20219:00 amRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20219:00 amRNSTotal Voting Rights
30th Mar 202110:00 amRNSNotice of Trading Update
18th Mar 20212:30 pmRNSDirector/PDMR Shareholding
10th Mar 202110:00 amRNSAdditional Listing
1st Mar 20214:00 pmRNSDirector Declaration
1st Mar 202110:00 amRNSTotal Voting Rights
1st Mar 20217:00 amRNSAcquisition of John Liscombe Limited
8th Feb 20217:00 amRNSTrading Statement
4th Feb 202110:00 amRNSHolding(s) in Company
2nd Feb 20212:30 pmRNSDirector/PDMR Shareholding
1st Feb 20219:01 amRNSBlock listing Interim Review
1st Feb 20219:00 amRNSTotal Voting Rights
27th Jan 202110:00 amRNSNotice of Trading Update
13th Jan 20217:00 amRNSCompletion of Synovos acquisition
4th Jan 202110:46 amRNSTotal Voting Rights
21st Dec 20202:30 pmRNSDirector/PDMR Shareholding
16th Dec 20209:30 amRNSHolding(s) in Company
15th Dec 20202:35 pmRNSHolding(s) in Company
11th Dec 202011:00 amRNSDirectorate Change
10th Dec 20204:17 pmRNSResults of the Placing
10th Dec 20207:20 amRNSRetail Offer via PrimaryBid.com
10th Dec 20207:18 amRNSProposed Placing of Ordinary Shares
10th Dec 20207:14 amRNSStrategically Attractive Acquisitions and Placing
4th Dec 202010:00 amRNSHolding(s) in Company
3rd Dec 20204:05 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
20th Nov 202010:30 amRNSDirector/PDMR Shareholding
20th Nov 202010:30 amRNSRefinancing of Group Debt facilities
17th Nov 20203:25 pmRNSHolding(s) in Company
17th Nov 20202:30 pmRNSAdditional Listing
12th Nov 202011:28 amRNSDirector/PDMR Shareholding
10th Nov 202010:00 amRNSDividend Declaration
10th Nov 20207:00 amRNSHalf-year Report
2nd Nov 202010:30 amRNSTotal Voting Rights
8th Oct 20207:00 amRNSTrading Statement
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 202010:00 amRNSTotal Voting Rights
21st Sep 202010:30 amRNSNotice of Trading Update
18th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.